Further, NLRP3 and IL-1β have been shown to be overexpressed in melanoma samples, and targeting tumor-associated NLRP3 prevents melanoma growth by reducing the expansion of myeloid-derived suppressor cells (MDSCs) [38]. The gene discussed is NLRP3; the disease is neoplasm.